Spss version 17.0 spss

All experiments were performed in triplicates. Statistical analyses were carried out using the statistical program SPSS Version 17.0 SPSS (SPSS Inc. Chicago, IL, USA). One-way ANOVA was used to compare mean values. The LSD multiple comparisons post hoc test was used to determine p values. Results were presented as mean ± standard deviation (SD) and considered significantly different when p < 0.05.

The data were statistically analyzed by SPSS Version 17.0 SPSS (SPSS Inc. Chicago, IL, USA). All analyses were carried out in triplicate, and the results are reported as the mean ± standard deviation (SD). Statistical analysis of the pharmacokinetic study was carried out using DAS 2.0 software (Drug and Statistics software, Shaanxi University of Traditional Chinese Medicine, Shaanxi, China). A value of P < 0.05 was regarded as a significant difference.

The results are expressed as the median (range) or mean ± SEM (standard error of the mean). Comparisons between the two groups were analyzed by the Wilcoxon rank-sum test. In correlation analyses, the Spearman's correlation test was used for the non-normal distribution data, and the Pearson's correlation test was used for the normal distribution data. Patient overall survival was defined as the time interval between the date of surgery and the date of death or last follow-up. Deaths due to causes other than RCC were not included in the death record. The cumulative survival time was analyzed with the use of Kaplan-Meier method, and the log-rank test was used to compare group differences. All statistical tests were performed using GraphPad Prism 6.0 software (GraphPad, San Diego, CA, United States) and SPSS (version 17.0; SPSS, Inc., Chicago, IL, USA). P<0.05 was considered statistically significant.